• Publications:
• Prevalence of Autoimmune Diseases in Thymic Epithelial Tumors (TET) Insights from RYTHMIC
• Autoimmune diseases in centrally reviewed Thymic Epithelial Tumors (TET)
• Increased incidence of thymic epithelial tumors during COVID-19 pandemic: A retrospective analysis from the French RYTHMIC network
• Outcomes of thymic epithelial tumors (TETs) with pleural metastases: Real-world insight from RYTHMIC.
• Pathological central review of 290 thymic epithelial tumors (TET) : The national network RYTHMIC experience.
• Pathomics-based prediction of thymic epithelial tumor subtypes within the French RYTHMIC network
• Pathomics-based prediction of thymic epithelial tumor subtypes within the French RYTHMIC network.
• Real World Data of everolimus in patients with Thymic epithelial tumors (TETs)
• Real World Data of lenvatinib in patients with Thymic epithelial tumors (TETs)
• Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network
• Systemic therapy in advanced thymic epithelial tumors: Insights from the RYTHMIC prospective cohort
• Synopsis: RYTHMIC_résumé_20160527.pdf
• Autre document: Etudes ancillaires